AF
MRVI icon

Allworth Financial’s Maravai LifeSciences MRVI Stock Holding History

Allworth Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Buy
2,503
+124
+5% +$535 ﹤0.01% 3389
2026
Q1 		$6.73K Buy
2,379
+200
+9% +$678 ﹤0.01% 3772
2025
Q4 		$7.08K Buy
2,179
+54
+3% +$182 ﹤0.01% 3501
2025
Q3 		$6.1K Buy
2,125
+1,822
+601% +$4.65K ﹤0.01% 3436
2025
Q2 		$731 Buy
303
+169
+126% +$355 ﹤0.01% 4040
2025
Q1 		$278 Sell
134
-559
-81% -$2.21K ﹤0.01% 3814
2024
Q4 		$3.69K Buy
693
+3
+0.4% +$19 ﹤0.01% 2893
2024
Q3 		$5.73K Sell
690
-61
-8% -$527 ﹤0.01% 2506
2024
Q2 		$6.49K Sell
751
-544
-42% -$4.7K ﹤0.01% 2396
2024
Q1 		$11.2K Buy
1,295
+627
+94% +$4.24K ﹤0.01% 2056
2023
Q4 		$4.38K Buy
668
+278
+71% +$1.8K ﹤0.01% 2325
2023
Q3 		$3.9K Buy
390
+175
+81% +$1.92K ﹤0.01% 2234
2023
Q2 		$2.67K Sell
215
-202
-48% -$2.73K ﹤0.01% 2372
2023
Q1 		$5.84K Buy
417
+329
+374% +$4.72K ﹤0.01% 1980
2022
Q4 		$1.26K Buy
88
+8
+10% +$126 ﹤0.01% 2402
2022
Q3 		$2K Buy
+80
New +$2.01K ﹤0.01% 2180

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Allworth Financial's MRVI Position: Q2 2026 in Review

Allworth Financial increased its Maravai LifeSciences (MRVI) stake by 5.2% in Q2 2026, buying an estimated $535 and bringing the position to 2,503 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3389.

Allworth Financial first reported a position in MRVI in Q3 2022 and has held it in 16 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Allworth Financial held 2,503 shares of Maravai LifeSciences worth $15.6K as of Q2 2026.
  • Allworth Financial bought 124 Maravai LifeSciences shares in Q2 2026, an estimated $535.
  • Maravai LifeSciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3389 holding.
  • Allworth Financial first reported a position in Maravai LifeSciences in Q3 2022 and has held it in 16 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.